Year-end Sale % OFF 
Abstract
The trace element selenium is known to manifest antitumor activity. There is a relationship between the development of cancer and selenium content in food. Recent data demonstrated the necessity of increasing selenium consumption for the prevention and treatment of oncological diseases. Certain features of cancer cells and potential targets of selenium therapy are discussed. Both natural forms of selenium, namely, element Se, sodium selenite, L-selenocystine, L-selenomethionine, and L-methylselenocysteine, and synthetic ones, methylseleninic acid and imidoselenocarbamate derivatives, which display antitumor activity due to the generation of methylselenol and hydrogen selenide, the main anticarcinogenic metabolites, are reviewed. New promising anticancer selenium compounds, diacetophenonyl selenide, 2-methylselanyl-1-phenylethanol, and amino acids 2-amino-3-selanyl butanoic acid and 2-amino-3-(methylselanyl) butanoic acid are discussed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
